The sGC stimulator BAY 41-8543 in a rat model of hypertension-induced heart failure

被引：0
|
作者：
N Haase
N Wilck
L Marko
A Balogh
A Heuser
D Brockschnieder
A Kretschmer
J P Stasch
N Müller
R Dechend
机构：
[1] Max-Delbrueck Ctr. & Medical Faculty of Charite,Experimental and Clinical Research Ctr.
[2] Max-Delbrueck Ctr.,undefined
[3] Bayer HealthCare,undefined
[4] Global Drug Discovery,undefined
[5] Helios Klinik,undefined
来源：
BMC Pharmacology and Toxicology | / 16卷 / Suppl 1期
关键词：
Total Peripheral Resistance; Angiotensinogen; Hemodynamic Monitoring; Diastolic Heart Failure; Pressure Volume Relationship;
D O I：
10.1186/2050-6511-16-S1-A57
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Mechanisms of transition from hypertension-induced hypertrophy to heart failure in the spontaneously hypertensive rat prone to heart failure.
    Cohuet, GMS
    Hermans, JJR
    Smits, JFM
    Struijker-Boudier, HAJ
    HYPERTENSION, 2005, 46 (04) : 911 - 911
  • [32] The effects of the sGC stimulator BAY 41-2272 in an experimental model of Duchenne Muscular Dystrophy (DMD)
    Krishnan, Shalini Murali
    Hagelschuer, Ina
    Mathar, Ilka
    Meyer, Jutta
    Hartmann, Elke
    Pavkovic, Mira
    Sandner, Peter
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [33] Hypertension-induced heart failure disrupts cardiac sympathetic innervation
    Scalco, Arianna
    Lee, Ethan N.
    Johnson, Morgan A.
    Sorensen, Michelle L.
    Hilton, Thomas N.
    Omonaka, Riley K.
    Zeimantz, Shae
    Aicher, Sue A.
    Woodward, William R.
    Habecker, Beth A.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2024, 327 (06): : H1544 - H1558
  • [34] Polyphenolic derivatives from propolis attenuates hypertension-induced heart failure
    Ku, H. C.
    PLANTA MEDICA, 2019, 85 (18) : 1543 - 1543
  • [35] Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure
    Redout, Everaldo M.
    van der Toorn, Annette
    Zuidwijk, Marian J.
    van de Kolk, Cees W. A.
    van Echteld, Cees J. A.
    Musters, Rene J. P.
    van Hardeveld, Cornelis
    Paulus, Walter J.
    Simonides, Warner S.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 298 (03): : H1038 - H1047
  • [36] Pharmacological inhibition of ε PKC prevents the progression of hypertension-induced heart failure
    Inagaki, Koichi
    Koyanagi, Tomoyoshi
    Wong, Lily
    Petrauskene, Olga V.
    Mochly-Rosen, Daria
    CIRCULATION, 2006, 114 (18) : 442 - 442
  • [37] Mast cells and εPKC: A role in cardiac remodeling in hypertension-induced heart failure
    Palaniyandi, Suresh Selvaraj
    Inagaki, Koichi
    Mochly-Rosen, Daria
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 (06) : 779 - 786
  • [38] ANTIFIBROTIC EFFECT OF THE SGC-STIMULATOR BAY 41-2272 IN THE BILE DUCT LIGATION LIVER FIBROSIS MODEL IN RATS
    Nowatzky, Janina
    Wintermeyer, Philip
    von Degenfeld, Georges
    Hirth-Dietrich, Claudia
    Sandner, Peter
    HEPATOLOGY, 2011, 54 : 755A - 755A
  • [39] The sGC Stimulator Vericiguat Improved Outcome in a Rodent Model of Heart Failure With Preserved Ejection Fraction (HFpEF)
    Mathar, Ilka
    Pavkovic, Mira
    Scheerer, Nina
    Hartmann, Elke
    Sandner, Peter
    CIRCULATION, 2018, 138
  • [40] Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure
    Dickinson, Brent A.
    Semus, Hillary M.
    Montgomery, Rusty L.
    Stack, Christianna
    Latimer, Paul A.
    Lewton, Steven M.
    Lynch, Joshua M.
    Hullinger, Thomas G.
    Seto, Anita G.
    van Rooij, Eva
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (06) : 650 - 659
12345